title: Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress.
abstract: Endothelium-derived microparticles have recently been described as a new marker of endothelial cell dysfunction. Increased levels of circulating microparticles have been documented in inflammatory disorders, diabetes mellitus, and many cardiovascular diseases. Perturbations of angiogenesis play an important role in the pathogenesis of these disorders. We demonstrated previously that isolated endothelial microparticles (EMPs) impair endothelial function in vitro, diminishing acetylcholine-induced vasorelaxation and nitric oxide production by rat aortic rings and simultaneously increasing superoxide production. Herein, using the Matrigel assay of angiogenesis in vitro and a topological analysis of the capillary-like network by human umbilical vein endothelial cells (HUVECs), we investigated the effects of EMPs on formation of the vascular network. All parameters of angiogenesis were affected by treatment for 48 h with isolated EMPs in a concentration of 10(5) but not 10(3) or 10(4) EMPs/ml. The effects included decreases in total capillary length (24%), number of meshes (45%), and branching points (36%) and an increase in mesh area (38%). The positional and topological order indicated that EMPs affect angiogenic parameters uniformly over the capillary network. Treatment with the cell-permeable SOD mimetic Mn(III)tetrakis(4-benzoic acid) porphyrin chloride (Mn-TBAP) partially or completely restored all parameters of angiogenesis affected by EMPs. EMPs reduced cell proliferation rate and increased apoptosis rate in time- and dose-dependent manners, and this phenomenon was also prevented by Mn-TBAP treatment. Our data demonstrate that EMPs have considerable impact on angiogenesis in vitro and may be an important contributor to the pathogenesis of diseases that are accompanied by impaired angiogenesis.
authors.affiliation: Department of Medicine, New York Medical College, BSB, R-C21, Valhalla, NY 10595, USA.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Mezentsev
authors.forename: Roeland M H
authors.initials: RM
authors.lastname: Merks
authors.forename: Edmond
authors.initials: E
authors.lastname: O'Riordan
authors.forename: Jun
authors.initials: J
authors.lastname: Chen
authors.forename: Natalia
authors.initials: N
authors.lastname: Mendelev
authors.forename: Michael S
authors.initials: MS
authors.lastname: Goligorsky
authors.forename: Sergey V
authors.initials: SV
authors.lastname: Brodsky
mesh_terms: D017209:Apoptosis / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism* / Q000648:ultrastructure; D003094:Collagen; D004338:Drug Combinations; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism* / Q000648:ultrastructure; D016166:Free Radical Scavengers / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007797:Laminin; D008665:Metalloporphyrins / Q000494:pharmacology; D018919:Neovascularization, Physiologic / Q000502:physiology*; D018384:Oxidative Stress / Q000502:physiology*; D011509:Proteoglycans; D013482:Superoxide Dismutase / Q000378:metabolism; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D004338:Drug Combinations; D016166:Free Radical Scavengers; D007797:Laminin; D008665:Metalloporphyrins; D011509:Proteoglycans; C097284:manganese(III)-tetrakis(4-benzoic acid)porphyrin; C059485:matrigel; D003094:Collagen; D013482:Superoxide Dismutase